ES549713A0 - Un procedimiento para preparar 1,4-dihidropiridinas - Google Patents

Un procedimiento para preparar 1,4-dihidropiridinas

Info

Publication number
ES549713A0
ES549713A0 ES549713A ES549713A ES549713A0 ES 549713 A0 ES549713 A0 ES 549713A0 ES 549713 A ES549713 A ES 549713A ES 549713 A ES549713 A ES 549713A ES 549713 A0 ES549713 A0 ES 549713A0
Authority
ES
Spain
Prior art keywords
dihydropyridines
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549713A
Other languages
English (en)
Other versions
ES8706670A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES549713A0 publication Critical patent/ES549713A0/es
Publication of ES8706670A1 publication Critical patent/ES8706670A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES549713A 1984-12-10 1985-12-09 Un procedimiento para preparar 1,4-dihidropiridinas Expired ES8706670A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/680,036 US4578394A (en) 1984-12-10 1984-12-10 Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines

Publications (2)

Publication Number Publication Date
ES549713A0 true ES549713A0 (es) 1987-06-16
ES8706670A1 ES8706670A1 (es) 1987-06-16

Family

ID=24729393

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549713A Expired ES8706670A1 (es) 1984-12-10 1985-12-09 Un procedimiento para preparar 1,4-dihidropiridinas

Country Status (7)

Country Link
US (1) US4578394A (es)
EP (1) EP0187251A3 (es)
JP (1) JPS61143376A (es)
DK (1) DK568285A (es)
ES (1) ES8706670A1 (es)
GR (1) GR852956B (es)
PT (1) PT81629B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816416A (en) * 1986-08-27 1989-03-28 Paul Averback Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions
US5231170A (en) * 1986-08-27 1993-07-27 Paul Averback Antibodies to dense microspheres
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5242934A (en) * 1992-03-02 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5187169A (en) * 1992-04-10 1993-02-16 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5214060A (en) * 1992-04-10 1993-05-25 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5276043A (en) * 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5824692A (en) * 1995-01-06 1998-10-20 Lippiello; Patrick Michael Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
JP5003014B2 (ja) * 2005-07-14 2012-08-15 住友化学株式会社 カルボキサミド化合物及びその植物病害防除用途
JP5034293B2 (ja) * 2005-07-14 2012-09-26 住友化学株式会社 カルボキサミド化合物及びこれを含有する植物病害防除剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083378A1 (en) * 1981-12-22 1983-07-13 Chugai Seiyaku Kabushiki Kaisha Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
US4578394A (en) 1986-03-25
GR852956B (es) 1986-04-01
EP0187251A3 (en) 1987-04-29
DK568285A (da) 1986-06-11
DK568285D0 (da) 1985-12-09
PT81629A (en) 1986-01-01
EP0187251A2 (en) 1986-07-16
ES8706670A1 (es) 1987-06-16
PT81629B (en) 1987-10-13
JPS61143376A (ja) 1986-07-01

Similar Documents

Publication Publication Date Title
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES548137A0 (es) Un procedimiento para preparar 9-amino-1,2,3,4-tetrahidro- acridin-1-ol y compuestos relacionados
ES543732A0 (es) Un procedimiento para preparar derivados de aminoalquilfenaxi.
ES551518A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES549713A0 (es) Un procedimiento para preparar 1,4-dihidropiridinas
ES553610A0 (es) Un procedimiento para preparar derivados de alanil-protina.
ES551564A0 (es) Un procedimiento para la preparacion de nuevas 1,4-dihidropiridinas
ES546285A0 (es) Un metodo para preparar 6-cloro-n-metil-2,3,4,5-tetrahidro- 1h-3-benzazepina
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES552032A0 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES543517A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
ES543997A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
ES554373A0 (es) Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos
ES552772A0 (es) Un procedimiento para producir 2,3,4-tri-o-acil-d- y-o l-hexosas
ES539592A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,4-dihidropiridina.
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa
ES549472A0 (es) Un procedimiento para preparar 1-beta-d-ribofuranosil-1,2,4-triazol-3-carboxamida.
ES540589A0 (es) Un procedimiento para preparar 2-arilimidazo (4,5-c) piridi-nas.
ES557636A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina
ES551361A0 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
ES551041A0 (es) Un procedimiento para preparar (1,2,4-oxadiazol-3-il)-arilmetanonas